The Impact of Pharmacokinetic Variability on Drug Dosing
American Journal of Pharmaceutics · 2020-08-31 · 1 (4) · 1-14
DOI: 10.71465/ajph1878 ↗At a glance
Journal article in American Journal of Pharmaceutics, published online on 2020-08-31. Written by Dr. Zain Ali. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Pharmacokinetics (PK) plays a crucial role in determining the optimal drug dosing regimen for individual patients. Variability in pharmacokinetic parameters such as absorption, distribution, metabolism, and elimination often leads to significant differences in drug responses among patients. These differences can impact the efficacy and safety of medications, especially in those with comorbidities, elderly patients, or those on polypharmacy. This paper explores the various factors that contribute to pharmacokinetic variability, including genetic factors, age, gender, disease state, and drug-drug interactions, and how these influence drug dosing strategies. The review also discusses strategies to mitigate the impact of PK variability through personalized medicine, therapeutic drug monitoring, and dose adjustments.
Cite
APA
Ali, D. Z. (2020). The Impact of Pharmacokinetic Variability on Drug Dosing. American Journal of Pharmaceutics, 1(4), 1-14. https://doi.org/10.71465/ajph1878
Vancouver
Ali DZ. The Impact of Pharmacokinetic Variability on Drug Dosing. American Journal of Pharmaceutics. 2020;1(4):1-14. doi:10.71465/ajph1878
BibTeX
@article{Ali2020,
author = {Ali, Dr. Zain},
title = {The Impact of Pharmacokinetic Variability on Drug Dosing},
journal = {American Journal of Pharmaceutics},
year = {2020},
volume = {1},
number = {4},
pages = {1--14},
doi = {10.71465/ajph1878}
}
EUVIMED